David M. Reese - Apr 30, 2024 Form 4 Insider Report for AMGEN INC (AMGN)

Role
EVP & Chief Technology Officer
Signature
/s/ David M. Reese
Stock symbol
AMGN
Transactions as of
Apr 30, 2024
Transactions value $
-$190,702
Form type
4
Date filed
5/1/2024, 07:54 PM
Previous filing
Mar 20, 2024
Next filing
May 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction AMGN Common Stock Tax liability -$191 K -690 -1.14% $276.38 60 K Apr 30, 2024 Direct F1, F2

Explanation of Responses:

Id Content
F1 These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,180 RSUs which will vest on 5/5/2024; 1,363 RSUs which will vest on 4/30/2025; 3,897 RSUs which will vest in two installments of 1,286 each on 5/2/2024 and 5/2/2025, and one installment of 1,325 on 5/2/2026; and 3,814 RSUs which will vest in installments of 1,258 on 5/2/2025, 1,259 on 5/2/2026, and 1,297 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
F2 These shares include 694 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.